Anika Rotator-Cuff Treatment May Launch in 1Q Following Final FDA Approval
18 August 2023 - 9:57AM
Dow Jones News
By Adam L. Cataldo
Anika Therapeutics expects to release its treatment for
rotator-cuff repairs in early 2024 after it received final 510(k)
clearance from the U.S. Food and Drug Administration.
The Integrity Implant System is designed to promote healing by
augmenting an injured tendon following rotator-cuff-repair
procedures, the company said.
Based in Bedford, Mass., Anika Therapeutics is a
joint-preservation company focused on early intervention
orthopedics.
A limited market release of the system in the U.S. is expected
to begin in the first quarter, the company said. A wider release in
the U.S. and expansion into international markets will follow.
The U.S. market for rotator-cuff augmentation is estimated at
$150 million and is growing at a nearly 7% compound annual growth
rate over the next five years, the company said.
Write to Adam Cataldo at adam.cataldo@wsj.com.
(END) Dow Jones Newswires
August 17, 2023 19:42 ET (23:42 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Apr 2024 to May 2024
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From May 2023 to May 2024
